{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T12:10:28Z","timestamp":1791807028814,"version":"4.3.4"},"reference-count":50,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,5,9]],"date-time":"2025-05-09T00:00:00Z","timestamp":1746748800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100002322","name":"Coordena\u00e7\u00e3o de Aperfei\u00e7oamento de Pessoal de N\u00edvel Superior","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002322","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pathology - Research and Practice"],"published-print":{"date-parts":[[2025,6]]},"DOI":"10.1016\/j.prp.2025.155997","type":"journal-article","created":{"date-parts":[[2025,5,6]],"date-time":"2025-05-06T12:06:30Z","timestamp":1746533190000},"page":"155997","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"special_numbering":"C","title":["Infiltrating Natural Killer cells influence the efficacy of BCG immunotherapy in non-muscle-invasive bladder cancer"],"prefix":"10.1016","volume":"270","author":[{"given":"Mariana Z.T.","family":"Lima","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diogo A.","family":"Bastos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Romulo L.","family":"Mattedi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlos","family":"Dzik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Denis L.F.","family":"Jardim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rafael","family":"Coelho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leopoldo A.","family":"Ribeiro-Filho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maur\u00edcio D.","family":"Cordeiro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William C.","family":"Nahas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Evandro S.","family":"Mello","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mariane T.","family":"Amano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lilian T.","family":"Inoue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anamaria A.","family":"Camargo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.prp.2025.155997_bib1","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.eururo.2021.08.010","article-title":"European Association of Urology Guidelines on Non\u2013muscle-invasive Bladder Cancer (Ta, T1, and Carcinoma in Situ)","volume":"81","author":"Babjuk","year":"2022","journal-title":"Eur. Urol."},{"key":"10.1016\/j.prp.2025.155997_bib2","doi-asserted-by":"crossref","first-page":"3073","DOI":"10.3390\/cancers14133073","article-title":"BCG in bladder cancer immunotherapy","volume":"14","author":"Jiang","year":"2022","journal-title":"Cancers"},{"key":"10.1016\/j.prp.2025.155997_bib3","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1038\/s41585-018-0055-4","article-title":"Mechanisms of BCG immunotherapy and its outlook for bladder cancer","volume":"15","author":"Pettenati","year":"2018","journal-title":"Nat. Rev. Urol."},{"key":"10.1016\/j.prp.2025.155997_bib4","doi-asserted-by":"crossref","first-page":"2796","DOI":"10.1016\/S0140-6736(16)30512-8","article-title":"Bladder cancer","volume":"388","author":"Kamat","year":"2016","journal-title":"Lancet"},{"key":"10.1016\/j.prp.2025.155997_bib5","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1007\/s00345-009-0402-4","article-title":"Quantification of the survival benefit of early versus deferred cystectomy in high-risk non-muscle invasive bladder cancer (T1 G3)","volume":"27","author":"Hautmann","year":"2009","journal-title":"World J. Urol."},{"key":"10.1016\/j.prp.2025.155997_bib6","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.euf.2019.04.002","article-title":"Recurrence rate and cost consequence of the shortage of bacillus calmette-gu\u00e9rin connaught strain for bladder cancer patients","volume":"7","author":"Ourfali","year":"2021","journal-title":"Eur. Urol. Focus"},{"key":"10.1016\/j.prp.2025.155997_bib7","doi-asserted-by":"crossref","DOI":"10.1200\/JCO.2019.37.7_suppl.442","article-title":"Tumor mutational burden (TMB) and BCG responsiveness in high-risk non-muscle invasive bladder cancer (NMIBC)","volume":"37","author":"Bastos","year":"2019","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.prp.2025.155997_bib8","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1038\/nrurol.2014.15","article-title":"The mechanism of action of BCG therapy for bladder cancer\u2014a current perspective","volume":"11","author":"Redelman-Sidi","year":"2014","journal-title":"Nat. Rev. Urol."},{"key":"10.1016\/j.prp.2025.155997_bib9","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1016\/j.eururo.2017.10.003","article-title":"Predicting Response to Intravesical Bacillus Calmette-Gu\u00e9rin Immunotherapy: Are We There Yet? A Systematic Review","volume":"73","author":"Kamat","year":"2018","journal-title":"Eur. Urol."},{"key":"10.1016\/j.prp.2025.155997_bib10","doi-asserted-by":"crossref","first-page":"1270","DOI":"10.3389\/fonc.2019.01270","article-title":"Immune responses in bladder cancer-role of immune cell populations, prognostic factors and therapeutic implications","volume":"9","author":"Joseph","year":"2019","journal-title":"Front Oncol."},{"key":"10.1016\/j.prp.2025.155997_bib11","doi-asserted-by":"crossref","first-page":"1971","DOI":"10.1007\/s00262-023-03376-9","article-title":"Tumour microenvironment as a predictive factor for immunotherapy in non-muscle-invasive bladder cancer","volume":"72","author":"Semeniuk-Wojta\u015b","year":"2023","journal-title":"Cancer Immunol. Immunother."},{"key":"10.1016\/j.prp.2025.155997_bib12","doi-asserted-by":"crossref","first-page":"4599","DOI":"10.1158\/1078-0432.CCR-21-0205","article-title":"Identification of a Novel Inflamed Tumor Microenvironment Signature as a Predictive Biomarker of Bacillus Calmette-Gu\u00e9rin Immunotherapy in Non\u2013Muscle-Invasive Bladder Cancer","volume":"27","author":"Damrauer","year":"2021","journal-title":"Clin. Cancer Res"},{"key":"10.1016\/j.prp.2025.155997_bib13","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1186\/s13046-024-02955-7","article-title":"High and selective cytotoxicity of ex vivo expanded allogeneic human natural killer cells from peripheral blood against bladder cancer: implications for natural killer cell instillation after transurethral resection of bladder tumor","volume":"43","author":"Wang","year":"2024","journal-title":"J. Exp. Clin. Cancer Res"},{"key":"10.1016\/j.prp.2025.155997_bib14","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1038\/s41423-019-0224-2","article-title":"Targeting natural killer cells in solid tumors","volume":"16","author":"Habif","year":"2019","journal-title":"Cell Mol. Immunol."},{"key":"10.1016\/j.prp.2025.155997_bib15","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1038\/s41568-020-0272-z","article-title":"The cancer\u2013natural killer cell immunity cycle","volume":"20","author":"Huntington","year":"2020","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.prp.2025.155997_bib16","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1038\/s41392-022-01058-z","article-title":"Natural killer cell homing and trafficking in tissues and tumors: from biology to application","volume":"7","author":"Ran","year":"2022","journal-title":"Signal Transduct. Target Ther."},{"key":"10.1016\/j.prp.2025.155997_bib17","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1016\/j.trecan.2022.03.007","article-title":"Natural killer cells: unlocking new treatments for bladder cancer","volume":"8","author":"Ranti","year":"2022","journal-title":"Trends Cancer"},{"key":"10.1016\/j.prp.2025.155997_bib18","article-title":"Inhibitory receptors and checkpoints on NK cells: Implications for cancer immunotherapy","volume":"253","author":"Li","year":"2024","journal-title":"Pathol. - Res Pr."},{"key":"10.1016\/j.prp.2025.155997_bib19","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1016\/j.ccell.2023.02.016","article-title":"The evolving tumor microenvironment: From cancer initiation to metastatic outgrowth","volume":"41","author":"De Visser","year":"2023","journal-title":"Cancer Cell"},{"key":"10.1016\/j.prp.2025.155997_bib20","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1038\/s41585-020-0346-4","article-title":"Trained immunity as a molecular mechanism for BCG immunotherapy in bladder cancer","volume":"17","author":"Van Puffelen","year":"2020","journal-title":"Nat. Rev. Urol."},{"key":"10.1016\/j.prp.2025.155997_bib21","article-title":"Tumor infiltrating lymphocytes (TILs) \u2013 Pathologia, quo vadis? \u2013 A global survey","volume":"266","author":"Skok","year":"2025","journal-title":"Pathol. - Res Pr."},{"key":"10.1016\/j.prp.2025.155997_bib22","article-title":"Tumor-infiltrating lymphocytes predict survival in \u2265\u2009pT2 urothelial bladder cancer","volume":"237","author":"Ledderose","year":"2022","journal-title":"Pathol. - Res Pr."},{"key":"10.1016\/j.prp.2025.155997_bib23","doi-asserted-by":"crossref","first-page":"7332","DOI":"10.1016\/j.vaccine.2021.09.053","article-title":"Effects of Mycobacterium bovis Calmette et Gu\u00e9rin (BCG) in oncotherapy: bladder cancer and beyond","volume":"39","author":"Mukherjee","year":"2021","journal-title":"Vaccine"},{"key":"10.1016\/j.prp.2025.155997_bib24","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1038\/s41585-022-00608-y","article-title":"The dynamic roles of the bladder tumour microenvironment","volume":"19","author":"Lee","year":"2022","journal-title":"Nat. Rev. Urol."},{"key":"10.1016\/j.prp.2025.155997_bib25","doi-asserted-by":"crossref","first-page":"1386","DOI":"10.1016\/j.eururo.2009.01.040","article-title":"Bladder tumor infiltrating mature dendritic cells and macrophages as predictors of response to bacillus calmette-gu\u00e9rin immunotherapy","volume":"55","author":"Ayari","year":"2009","journal-title":"Eur. Urol."},{"key":"10.1016\/j.prp.2025.155997_bib26","doi-asserted-by":"crossref","first-page":"56","DOI":"10.3109\/01913123.2012.728688","article-title":"Prognostic value of tumor-associated macrophages count in human non-muscle-invasive bladder cancer treated by BCG immunotherapy","volume":"37","author":"Ajili","year":"2013","journal-title":"Ultra Pathol."},{"key":"10.1016\/j.prp.2025.155997_bib27","unstructured":"Pichler R., Fritz J., Zavadil C., Sch\u00e4fer G., Culig Z., Brunner A. oncologic outcome after intravesical Bacillus Calmette-Gu\u00e9rin n.d."},{"key":"10.1016\/j.prp.2025.155997_bib28","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.humpath.2019.04.003","article-title":"Tumor immune microenvironment in non\u2013muscle-invasive urothelial carcinoma of the bladder","volume":"89","author":"Eich","year":"2019","journal-title":"Hum. Pathol."},{"key":"10.1016\/j.prp.2025.155997_bib29","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.3390\/cancers15041205","article-title":"CD8+\u2009cell density gradient across the tumor epithelium\u2013stromal interface of non-muscle invasive papillary urothelial carcinoma predicts recurrence-free survival after BCG immunotherapy","volume":"15","author":"Drachneris","year":"2023","journal-title":"Cancers"},{"key":"10.1016\/j.prp.2025.155997_bib30","doi-asserted-by":"crossref","first-page":"1935","DOI":"10.1200\/JCO.2015.64.4070","article-title":"Definitions, end points, and clinical trial designs for non\u2013muscle-invasive bladder cancer: recommendations from the international bladder cancer group","volume":"34","author":"Kamat","year":"2016","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.prp.2025.155997_bib31","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1002\/1097-0215(20010601)92:5<697::AID-IJC1245>3.0.CO;2-Z","article-title":"NK cells are essential for effective BCG immunotherapy","volume":"92","author":"Brandau","year":"2001","journal-title":"Int J. Cancer"},{"key":"10.1016\/j.prp.2025.155997_bib32","doi-asserted-by":"crossref","first-page":"2660","DOI":"10.1016\/j.juro.2007.07.118","article-title":"The Expression Level of Ligands for Natural Killer Cell Receptors Predicts Response to Bacillus Calmette-Guerin Therapy: A Pilot Study","volume":"178","author":"Yutkin","year":"2007","journal-title":"J. Urol."},{"key":"10.1016\/j.prp.2025.155997_bib33","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1016\/j.ucl.2020.07.002","article-title":"Harnessing natural killer cell function for genitourinary cancers","volume":"47","author":"Bhardwaj","year":"2020","journal-title":"Urol. Clin. North Am."},{"key":"10.1016\/j.prp.2025.155997_bib34","doi-asserted-by":"crossref","DOI":"10.1172\/JCI145666","article-title":"BCG therapy downregulates HLA-I on malignant cells to subvert antitumor immune responses in bladder cancer","volume":"132","author":"Rouanne","year":"2022","journal-title":"J. Clin. Invest"},{"key":"10.1016\/j.prp.2025.155997_bib35","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.633361","article-title":"The adverse impact of tumor microenvironment on NK-cell","volume":"12","author":"Hu","year":"2021","journal-title":"Front Immunol."},{"key":"10.1016\/j.prp.2025.155997_bib36","unstructured":"Brandau S., Suttmann H., Riemensberger J., Seitzer U., Arnold J., Durek C., et al. Perforin-mediated Lysis of Tumor Cells by Mycobacterium Bovis Bacillus Calmette-Gue\u00b4rin-activated Killer Cells n.d."},{"key":"10.1016\/j.prp.2025.155997_bib37","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1159\/000052497","article-title":"B\u00f6hle A. Activation of Natural Killer Cells by Bacillus Calmette\u2013Gu\u00e9rin","volume":"39","author":"Brandau","year":"2001","journal-title":"Eur. Urol."},{"key":"10.1016\/j.prp.2025.155997_bib38","doi-asserted-by":"crossref","first-page":"1490","DOI":"10.1097\/01.ju.0000131944.52354.63","article-title":"Mechanisms of bacillus calmette-guerin mediated natural killer cell activation","volume":"172","author":"Suttmann","year":"2004","journal-title":"J. Urol."},{"key":"10.1016\/j.prp.2025.155997_bib39","first-page":"6","article-title":"NKG2D is a Key Receptor for Recognition of Bladder Cancer Cells by IL-2-Activated NK Cells and BCG Promotes NK Cell Activation","author":"Garc\u00c3\u00ada-Cuesta","year":"2015","journal-title":"Front Immunol."},{"key":"10.1016\/j.prp.2025.155997_bib40","doi-asserted-by":"crossref","DOI":"10.1080\/2162402X.2017.1293212","article-title":"Characterization of a human anti-tumoral NK cell population expanded after BCG treatment of leukocytes","volume":"6","author":"Garc\u00eda-Cuesta","year":"2017","journal-title":"OncoImmunology"},{"key":"10.1016\/j.prp.2025.155997_bib41","doi-asserted-by":"crossref","first-page":"1571","DOI":"10.1016\/j.juro.2008.11.124","article-title":"Molecular Analyte Profiling of the Early Events and Tissue Conditioning Following Intravesical Bacillus Calmette-Guerin Therapy in Patients With Superficial Bladder Cancer","volume":"181","author":"Bisiaux","year":"2009","journal-title":"J. Urol."},{"key":"10.1016\/j.prp.2025.155997_bib42","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/j.clim.2014.10.005","article-title":"BCG-induced trained immunity in NK cells: role for non-specific protection to infection","volume":"155","author":"Kleinnijenhuis","year":"2014","journal-title":"Clin. Immunol."},{"key":"10.1016\/j.prp.2025.155997_bib43","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1186\/s12967-023-03944-8","article-title":"BCG-induced trained immunity: history, mechanisms and potential applications","volume":"21","author":"Chen","year":"2023","journal-title":"J. Transl. Med"},{"key":"10.1016\/j.prp.2025.155997_bib44","doi-asserted-by":"crossref","first-page":"3038","DOI":"10.3389\/fimmu.2019.03038","article-title":"Influence of the tumor microenvironment on NK cell function in solid tumors","volume":"10","author":"Melaiu","year":"2020","journal-title":"Front Immunol."},{"key":"10.1016\/j.prp.2025.155997_bib45","doi-asserted-by":"crossref","first-page":"1701","DOI":"10.1016\/j.cell.2019.04.041","article-title":"Multifunctional natural killer cell engagers targeting NKp46 trigger protective tumor immunity","volume":"177","author":"Gauthier","year":"2019","journal-title":"Cell"},{"key":"10.1016\/j.prp.2025.155997_bib46","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1111\/j.1365-2567.2008.03027.x","article-title":"CD56 bright natural killer (NK) cells: an important NK cell subset","volume":"126","author":"Poli","year":"2009","journal-title":"Immunology"},{"key":"10.1016\/j.prp.2025.155997_bib47","unstructured":"Mukherjee N., Ji N., Hurez V., Curiel T.J., Braun A.J., Nicolas M., et al. Intratumoral CD56bright natural killer cells are associated with improved survival in bladder cancer n.d."},{"key":"10.1016\/j.prp.2025.155997_bib48","doi-asserted-by":"crossref","unstructured":"Felgueres 2024 - BCG priming followed by a novel interleukin combination activates Natural Killer cells to selectively proliferate and become anti-tumour long-lived effectors.pdf n.d.","DOI":"10.1038\/s41598-024-62968-2"},{"key":"10.1016\/j.prp.2025.155997_bib49","unstructured":"Lu L.-M., Zavitz C.C.J., Chen B., Kianpour S., Wan Y., St\u00e4mpfli M.R. Cigarette Smoke Impairs NK Cell-Dependent Tumor Immune Surveillance. J Immunol n.d."},{"key":"10.1016\/j.prp.2025.155997_bib50","doi-asserted-by":"crossref","first-page":"13","DOI":"10.15430\/JCP.2020.25.1.13","article-title":"Impact of smoking on human natural killer cell activity: a large cohort study","volume":"25","author":"Jung","year":"2020","journal-title":"J. Cancer Prev."}],"container-title":["Pathology - Research and Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S034403382500189X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S034403382500189X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,14]],"date-time":"2026-05-14T08:26:55Z","timestamp":1778747215000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S034403382500189X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6]]},"references-count":50,"alternative-id":["S034403382500189X"],"URL":"https:\/\/doi.org\/10.1016\/j.prp.2025.155997","relation":{},"ISSN":["0344-0338"],"issn-type":[{"value":"0344-0338","type":"print"}],"subject":[],"published":{"date-parts":[[2025,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Infiltrating Natural Killer cells influence the efficacy of BCG immunotherapy in non-muscle-invasive bladder cancer","name":"articletitle","label":"Article Title"},{"value":"Pathology - Research and Practice","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.prp.2025.155997","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier GmbH.","name":"copyright","label":"Copyright"}],"article-number":"155997"}}